These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation. Troyanovsky B; Levchenko T; MÃ¥nsson G; Matvijenko O; Holmgren L J Cell Biol; 2001 Mar; 152(6):1247-54. PubMed ID: 11257124 [TBL] [Abstract][Full Text] [Related]
23. Angiostatin induces mitotic cell death of proliferating endothelial cells. Hari D; Beckett MA; Sukhatme VP; Dhanabal M; Nodzenski E; Lu H; Mauceri HJ; Kufe DW; Weichselbaum RR Mol Cell Biol Res Commun; 2000 May; 3(5):277-82. PubMed ID: 10964751 [TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo induction of antiangiogenic activity by plasminogen activators and captopril. Merchan JR; Chan B; Kale S; Schnipper LE; Sukhatme VP J Natl Cancer Inst; 2003 Mar; 95(5):388-99. PubMed ID: 12618504 [TBL] [Abstract][Full Text] [Related]
25. Angiostatin diminishes activation of the mitogen-activated protein kinases ERK-1 and ERK-2 in human dermal microvascular endothelial cells. Redlitz A; Daum G; Sage EH J Vasc Res; 1999; 36(1):28-34. PubMed ID: 10050071 [TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen. Brauer R; Beck IM; Roderfeld M; Roeb E; Sedlacek R BMC Biochem; 2011 Jul; 12():38. PubMed ID: 21787393 [TBL] [Abstract][Full Text] [Related]
27. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action. Sharma MR; Rothman V; Tuszynski GP; Sharma MC Exp Mol Pathol; 2006 Oct; 81(2):136-45. PubMed ID: 16643891 [TBL] [Abstract][Full Text] [Related]
28. Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth. Yokoyama Y; Dhanabal M; Griffioen AW; Sukhatme VP; Ramakrishnan S Cancer Res; 2000 Apr; 60(8):2190-6. PubMed ID: 10786683 [TBL] [Abstract][Full Text] [Related]
29. Tumor necrosis factor-alpha and angiostatin are mediators of endothelial cytotoxicity in bronchoalveolar lavages of patients with acute respiratory distress syndrome. Hamacher J; Lucas R; Lijnen HR; Buschke S; Dunant Y; Wendel A; Grau GE; Suter PM; Ricou B Am J Respir Crit Care Med; 2002 Sep; 166(5):651-6. PubMed ID: 12204860 [TBL] [Abstract][Full Text] [Related]
30. Suppression of tumor growth with recombinant murine angiostatin. Wu Z; O'Reilly MS; Folkman J; Shing Y Biochem Biophys Res Commun; 1997 Jul; 236(3):651-4. PubMed ID: 9245707 [TBL] [Abstract][Full Text] [Related]
31. Angiostatin upregulates E-selectin in proliferating endothelial cells. Luo J; Lin J; Paranya G; Bischoff J Biochem Biophys Res Commun; 1998 Apr; 245(3):906-11. PubMed ID: 9588213 [TBL] [Abstract][Full Text] [Related]
32. Intracellular Ca(2+) signaling in endothelial cells by the angiogenesis inhibitors endostatin and angiostatin. Jiang L; Jha V; Dhanabal M; Sukhatme VP; Alper SL Am J Physiol Cell Physiol; 2001 May; 280(5):C1140-50. PubMed ID: 11287327 [TBL] [Abstract][Full Text] [Related]
33. Photodynamic therapy using Lu-Tex induces apoptosis in vitro, and its effect is potentiated by angiostatin in retinal capillary endothelial cells. Renno RZ; Delori FC; Holzer RA; Gragoudas ES; Miller JW Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3963-71. PubMed ID: 11053300 [TBL] [Abstract][Full Text] [Related]
34. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3). Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331 [TBL] [Abstract][Full Text] [Related]
35. Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin. Tarui T; Majumdar M; Miles LA; Ruf W; Takada Y J Biol Chem; 2002 Sep; 277(37):33564-70. PubMed ID: 12087108 [TBL] [Abstract][Full Text] [Related]
36. Angiostatin: a negative regulator of endothelial-dependent vasodilation. Koshida R; Ou J; Matsunaga T; Chilian WM; Oldham KT; Ackerman AW; Pritchard KA Circulation; 2003 Feb; 107(6):803-6. PubMed ID: 12591747 [TBL] [Abstract][Full Text] [Related]
37. Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site. Ahn JH; Lee HJ; Lee EK; Yu HK; Lee TH; Yoon Y; Kim SJ; Kim JS Biol Chem; 2011 Apr; 392(4):347-56. PubMed ID: 21194375 [TBL] [Abstract][Full Text] [Related]
38. Angiostatin and angiostatin-related proteins. Soff GA Cancer Metastasis Rev; 2000; 19(1-2):97-107. PubMed ID: 11191071 [TBL] [Abstract][Full Text] [Related]
39. Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin. Gately S; Twardowski P; Stack MS; Patrick M; Boggio L; Cundiff DL; Schnaper HW; Madison L; Volpert O; Bouck N; Enghild J; Kwaan HC; Soff GA Cancer Res; 1996 Nov; 56(21):4887-90. PubMed ID: 8895739 [TBL] [Abstract][Full Text] [Related]
40. Binding of the NG2 proteoglycan to kringle domains modulates the functional properties of angiostatin and plasmin(ogen). Goretzki L; Lombardo CR; Stallcup WB J Biol Chem; 2000 Sep; 275(37):28625-33. PubMed ID: 10889192 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]